Federal grants to Glytr Therapeutics, Inc.
Glytr Therapeutics, Inc. in Irvine, California received $3.3 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cancer Treatment Research, with $2.9 million. In fiscal 2025 it was awarded $1.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.3 million
- Awards3
- Awarded in FY 2025$1.5 million
- Largest award$2.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $398,178 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $400,000 |
| FY 2024 | 1 | $908,910 |
| FY 2025 | 2 | $1.5 million |
Programs that fund Glytr Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 2 | $2.9 million |
| Cancer Biology Research | 1 | $398,178 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $3.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Extended?half-life?GLYTR1 combined with checkpoint blockade?for cancer immunotherapy - abstract treatment of non-resectable recurrent/metastatic solid cancers is currently palliative only and there is an urgent unmet need for novel mechanisms of action and additional paradigm shifting therapeutic op | Cancer Treatment Research | September 20, 2023 | $2.4 million |
| Maximizing glytr pan-cancer immunotherapy by enhancing target density - abstract bi-specific antibodies and chimeric antigen receptor t-cells are the most potent cancer immunotherapeutics in clinical use, yet most cancers remain poorly targetable. High-affinity antibodies required to maximize killin | Cancer Treatment Research | September 10, 2025 | $463,510 |
| Cancer immunotherapy targeting tn antigen - abstract cancer immunotherapeutic bi-specific proteins and engineered chimeric antigen receptor t cells (car t) have shown remarkable clinical activity, with complete response rates as high as ~90% for b cell malignancies. However, applying these two thera | Cancer Biology Research | July 28, 2021 | $398,178 |
Questions people ask
How much federal grant money does Glytr Therapeutics, Inc. get?
$3.3 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Glytr Therapeutics, Inc. the most?
The Department of Health and Human Services, with $3.3 million in 3 awards.
What is Glytr Therapeutics, Inc.'s largest federal grant?
$2.4 million under Cancer Treatment Research, with its first action in the period on September 20, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Glytr Therapeutics, Inc.?
Its largest are Cancer Treatment Research and Cancer Biology Research.
Other grant recipients in Irvine
- University of California Irvine
- Easter Seals Southern California, Inc.
- Charge Bliss, Inc
- South Orange County Community College District
- Irvine Ranch Water District
- City of Irvine
- Orange County Fire Authority
- University of Massachusetts Global
Largest federal grant recipients in California · Federal grants in California